Rimonabant | News and reports about Rimonabant

If you thought losing weight was a tedious and tough task, probably you haven’t heard about the gamut of diet pills that are available in the market. Weight loss is something, all obese and over weight individual would do anything to achieve it, and this trend is wide spread owing ...

Life is a competition for survival in which every living being have to beat disease, otherwise disease can beat him. Obesity is accompanied with many fatal diseases like heart attack, kidney failure, arthritis etc. All these diseases make life span shorter. Hence, beating obesity is essential to live longer. Weight reduction ...

Our body is the most complicated machinery which nature has ever created. There is a perfect coordination among all systems of the body. Nature has enabled human beings to accumulate fat beneath the skin which is there to provide them energy during hard days. This is because man came on ...

Obesity is becoming a cosmopolitan problem. It has created some major health related hazards globally like diabetes, chronic heart diseases, high blood pressure etc. In some nations like US and UK, it is a prevailing disease among both adults and children. The causes of obesity are considered a multifactoral problem. ...

Obesity is becoming the most common nutritional disorder in many industrialised country around the world. In countries like America and Europe it has reached epidemic levels. Furthermore, oflate there is an alarming rate of child obesity. This growing prevalence of obesity problem has stimulated the search of various anti obesity ...

IF anecdotes and ancient medicine are to be trusted, cannabis is a wonder drug. Yet results of clinical trials have been mixed and its use in modern medicine remains limited. Now it seems the reasons may be practical as much as political and cultural: there are fundamental problems with how ...

A new obesity wonder drug, Acomplia (rimonabant), makes patients lose 10% of their body weight, according to clinical trials carried out by Sanofi-Aventis, the third largest pharmaceutical company in the world. Sanofi-Aventis are hoping to have this drug on the market if all goes well. According to the trials, patients on a ...

Overweight or obese people who are stout around the waist and abdomen are particularly at high risk for developing type 2 diabetes and high blood pressure. The most effective way to reduce blood pressure and the risk for secondary diseases is to reduce weight. But most patients do not succeed ...

A new drug billed as a magic bullet for obesity - rimonabant (Acomplia) - does help people lose weight, although not that much weight, and also helps lower cardiac risk factors, according to a review of studies. Rimonabant went on sale in Europe in July, and U.S. approval is pending before ...

Is Rimonabant a new anti smoking drug? Effects of Rimonabant in the Reduction of Major Cardiovascular Risk Factors. Results from the STRATUS-US Trial (Smoking Cessation in Smokers Motivated to Quit and the RIO-LIPIDS Trial (Weight Reducing and Metabolic Effects in Overweight/Obese Patients with Dyslipidemia). Rimonabant, a selective cannabinoid type 1 receptor ...